Mengis Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,300
Closed -$218K 125
2018
Q3
$218K Sell
2,300
-1,400
-38% -$119K 0.12% 113
2018
Q2
$285K Hold
3,700
0.17% 103
2018
Q1
$255K Sell
3,700
-350
-9% -$26.7K 0.15% 109
2017
Q4
$302K Hold
4,050
0.18% 103
2017
Q3
$256K Sell
4,050
-50
-1% -$3.11K 0.17% 106
2017
Q2
$261K Hold
4,100
0.18% 105
2017
Q1
$270K Sell
4,100
-200
-5% -$13.8K 0.2% 101
2016
Q4
$295K Sell
4,300
-50
-1% -$3.58K 0.23% 91
2016
Q3
$306K Sell
4,350
-12,850
-75% -$961K 0.25% 91
2016
Q2
$1.3M Buy
17,200
+1,800
+12% +$132K 1.15% 32
2016
Q1
$1.06M Buy
15,400
+3,850
+33% +$277K 0.98% 36
2015
Q4
$1.01M Hold
11,550
0.88% 36
2015
Q3
$935K Buy
11,550
+800
+7% +$69.7K 0.87% 39
2015
Q2
$956K Buy
10,750
+2,000
+23% +$175K 0.8% 40
2015
Q1
$759K Buy
8,750
+2,600
+42% +$218K 0.66% 53
2014
Q4
$520K Buy
+6,150
New +$481K 0.5% 64

Other funds holding ESRX

Mengis Capital Management's ESRX Position: Q4 2018 in Review

Mengis Capital Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,300 shares — an estimated $218K sold.

Mengis Capital Management first reported a position in ESRX in Q4 2014 and held it in 16 quarters. The position peaked at $1.3M in Q2 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Mengis Capital Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Mengis Capital Management sold 2,300 Express Scripts Holding Company shares in Q4 2018, an estimated $218K.
  • Mengis Capital Management first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 16 quarters.
  • Mengis Capital Management's Express Scripts Holding Company position peaked at $1.3M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Mengis Capital Management's 13F filing for Q4 2018, filed 6 Feb 2019.